Similar Articles
111 Interleukin-17A facilitates tumor progression via upregulating programmed death ligand-1 expression in hepatocellular carcinoma
112 TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma
113 Advanced hepatocellular carcinoma treatment strategies: Are transarterial approaches leading the way?
114 Trends of alkaline phosphatase to prealbumin ratio in patients with hepatitis B linked to hepatocellular carcinoma development
115 Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression
116 Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection
117 N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression
118 Targeting hypoxia and angiogenesis in hepatocellular carcinoma: New insights and therapeutic strategies
119 Landscape of transarterial chemoembolization represented interventional therapy for hepatocellular carcinoma
120 Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA